« Back to Record
Van Cutsem, E., Dirix, L. Y., Van Laethem, J.-L., Van Belle, S., Borner, M., Gonzalez Baron, M., Roth, A., Morant, R., Joosens, E., Gruia, G., Sibaud, D., & Bleiberg, H. (2005). Optimisation of irinotecan dose in the treatment of patients with metastatic colorectal cancer after 5-FU failure: Results from a multinational, randomised phase II study. British Journal of Cancer, 92(6), 1055-1062. doi:10.1038/sj.bjc.6602462
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/90274



